Unbound MEDLINE

A Retrospective Evaluation of Completion Rates, Total Cost, and Adverse Effects for Treatment of Latent Tuberculosis Infection in a Public Health Clinic in Central Massachusetts. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] Journal article

 
TitleA Retrospective Evaluation of Completion Rates, Total Cost, and Adverse Effects for Treatment of Latent Tuberculosis Infection in a Public Health Clinic in Central Massachusetts.
Author(s)Young H, Wessolossky M, Ellis J, Kaminski M, Daly JS 
InstitutionDepartment of Medicine, University of Massachusetts Medical School, and 2Family Health Center, Worcester, Massachusetts.
SourceClin Infect Dis 2009 Jun 23.
AbstractCompletion rates, total cost, and adverse effects were compared for patients in central Massachusetts treated for latent tuberculosis infection with 9 months of isoniazid or 4 months of rifampin. Although the adverse effects were similar between the 2 groups, 4 months of rifampin was associated with significantly better completion rates and less hepatotoxicity yet higher total cost.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19548835
  
Advertise on this site.